Summit Partners Public Asset Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q3
Sell
-160,000
Closed -$7.01M 117
2019
Q2
$7.01M Buy
+160,000
New +$7.01M 0.7% 48